Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2009 1
2011 1
2012 1
2013 6
2014 4
2015 1
2017 1
2019 2
2020 3
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Latent cytokines for targeted therapy of inflammatory disorders.
Mullen L, Adams G, Layward L, Vessillier S, Annenkov A, Mittal G, Rigby A, Sclanders M, Baker D, Gould D, Chernajovsky Y. Mullen L, et al. Among authors: vessillier s. Expert Opin Drug Deliv. 2014 Jan;11(1):101-10. doi: 10.1517/17425247.2014.863872. Epub 2013 Dec 3. Expert Opin Drug Deliv. 2014. PMID: 24294995 Review.
Cellular Metrology: Scoping for a Value Proposition in Extra- and Intracellular Measurements.
Faruqui N, Kummrow A, Fu B, Divieto C, Rojas F, Kisulu F, Cavalcante JJV, Wang J, Campbell J, Martins JL, Choi JH, Sassi MP, Zucco M, Vonsky M, Vessillier S, Zou S, Fujii SI, Ryadnov MG. Faruqui N, et al. Among authors: vessillier s. Front Bioeng Biotechnol. 2020 Jan 14;7:456. doi: 10.3389/fbioe.2019.00456. eCollection 2019. Front Bioeng Biotechnol. 2020. PMID: 31993416 Free PMC article. Review.
Methods for targeting biologicals to specific disease sites.
Nissim A, Gofur Y, Vessillier S, Adams G, Chernajovsky Y. Nissim A, et al. Among authors: vessillier s. Trends Mol Med. 2004 Jun;10(6):269-74. doi: 10.1016/j.molmed.2004.04.003. Trends Mol Med. 2004. PMID: 15177191 Review.
Intrinsic host susceptibility among multiple species to intranasal SARS-CoV-2 identifies diverse virological, biodistribution and pathological outcomes.
Berry N, Ferguson D, Kempster S, Hall J, Ham C, Jenkins A, Rannow V, Giles E, Leahy R, Goulding S, Fernandez A, Adedeji Y, Vessillier S, Rajagopal D, Prior S, Le Duff Y, Hurley M, Gilbert S, Fritzsche M, Mate R, Rose N, Francis RJ, MacLellan-Gibson K, Suarez-Bonnet A, Priestnall S, Almond N. Berry N, et al. Among authors: vessillier s. Sci Rep. 2022 Nov 4;12(1):18694. doi: 10.1038/s41598-022-23339-x. Sci Rep. 2022. PMID: 36333445 Free PMC article.
Targeting cytokines to inflammation sites.
Adams G, Vessillier S, Dreja H, Chernajovsky Y. Adams G, et al. Among authors: vessillier s. Nat Biotechnol. 2003 Nov;21(11):1314-20. doi: 10.1038/nbt888. Epub 2003 Oct 5. Nat Biotechnol. 2003. PMID: 14528315
Mechanism of action, potency and efficacy: considerations for cell therapies.
Simon CG Jr, Bozenhardt EH, Celluzzi CM, Dobnik D, Grant ML, Lakshmipathy U, Nebel T, Peltier L, Ratcliffe A, Sherley JL, Stacey GN, Taghizadeh RR, Tan EHP, Vessillier S. Simon CG Jr, et al. Among authors: vessillier s. J Transl Med. 2024 May 2;22(1):416. doi: 10.1186/s12967-024-05179-7. J Transl Med. 2024. PMID: 38698408 Review.
25 results